Vorinostat Not Yet Recruiting Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01720875Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma